OTC Corticosteroid Dispensing System with Patient Qualification Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in making corticosteroids accessible over-the-counter for asthma treatment while ensuring safe and responsible use, as current attempts have failed due to concerns over inappropriate patient selection and medication misuse.
Innovation Solution
A system and method that qualify subjects for over-the-counter delivery of corticosteroid pharmaceutical compositions by conducting surveys and running results against filters for contraindications and risk factors, providing warnings and ensuring acknowledgment before dispensing the medication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If corticosteroids are made available over-the-counter to increase accessibility, then patient access and self-reliance are improved, but the risk of inappropriate patient selection and misuse increases
Solution Approach 1:
The patent implements preliminary qualification actions by requiring patients to complete a questionnaire and undergo phone screening before receiving OTC corticosteroids. This pre-screening process identifies appropriate candidates and filters out inappropriate users before medication dispensing, thereby enabling safe OTC access while preventing misuse.
Solution Approach 2:
The patent introduces an intermediary qualification system between the patient and the medication. This intermediary process includes questionnaires, phone screenings, and tracking mechanisms that mediate the interaction, ensuring patients meet safety criteria before receiving OTC corticosteroids, thus balancing accessibility with safety.
2Reliability
If a qualification system is implemented to ensure safe use, then patient safety is improved, but the complexity of the dispensing process increases
Solution Approach 1:
The patent segments the qualification process into distinct components: a written questionnaire, a phone screening step, and a tracking system. This segmentation allows each component to perform a specific safety function while keeping individual steps relatively simple, managing overall process complexity through modular design.
Solution Approach 2:
The patent implements self-service by requiring patients to independently complete the qualification questionnaire and provide necessary information. This reduces the burden on healthcare providers while maintaining safety standards, as patients actively participate in their own qualification process rather than requiring extensive provider intervention.
Data Source
AI summary
A method is provided for treating or preventing symptoms of asthma in a subject in need thereof by administering a corticosteroid pharmaceutical composition to a subject qualified for over-the-counter access to the corticosteroid pharmaceutical composition. In some embodiments, the corticosteroid pharmaceutical composition includes a class B corticosteroid, a glucocorticosteroid, budesonide, ciclesonide, fluticasone furoate, mometasone furoate, fluticasone propionate, or beclomethasone dipropionate.